NIH-funded research R01 grant

How PFAS chemicals affect cholesterol and heart disease

Official title: PFAS accelerate atherosclerosis through modulation of bile acid metabolism

Funded at Wayne State University · NIH-10658104 · Data updated 2026-11-12

This study is looking at how certain chemicals called PFAS might affect cholesterol levels and lead to heart problems, using a special mouse model that acts like humans, to help find new ways to protect people at risk of heart disease.

More Atherosclerosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startSeptember 19, 2023
Project endAugust 31, 2026
Funding year2023
Award (this year)$1,644,161
NIH project number1R01ES034407-01A1
Project IDNIH-10658104 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with elevated cholesterol levels or those at risk for atherosclerotic cardiovascular disease.

Less likely to help

Patients without cardiovascular risk factors or those not exposed to PFAS may not benefit from this research.

What this research studies

This research investigates the impact of per- and polyfluoroalkyl substances (PFAS) on cholesterol levels and the development of atherosclerosis, a major cardiovascular disease. Using a specific mouse model that mimics human cholesterol profiles, the study aims to understand how PFAS exposure accelerates the buildup of fatty deposits in arteries. By examining the relationship between PFAS, bile acid metabolism, and atherosclerosis, the research seeks to provide insights into the mechanisms that contribute to heart disease. The findings could help identify new risk factors and potential interventions for patients at risk of cardiovascular diseases.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and management of cardiovascular diseases linked to environmental toxins.

How similar studies have gone: While studies have shown PFAS can increase cholesterol in general, this specific approach using a human-like model for atherosclerosis is novel.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Petriello, Michael Curtis — Wayne State University
  • Study coordinator: Petriello, Michael Curtis

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.